Laparoscopic pelvic lymph node dissection, laparoscopically assisted seminal vesicle mobilization, and total perineal prostatectomy versus radical retropubic prostatectomy for prostate cancer

By Teichman J.M.H.   Reddy P.K.   Hulbert J.C.  

Urology, Vol. 45, Iss. 5, 1995-05 ,pp. : 823-830

Elsevier

Access to resources Recommend Favorite

Captopril may reduce biochemical (prostate-specific antigen) failure following radical prostatectomy for clinically localized prostate cancer

By Ronquist Gunnar   Frithz Goran   Wang Yu-Hui   Lindeborg Torsten  

Scandinavian Journal of Urology and Nephrology, Vol. 43, Iss. 1, 2009-02 ,pp. : 32-36

Informa Healthcare

Access to resources Recommend Favorite

Comparison of clinically nonpalpable prostate-specific antigen-detected (cT1c) versus palpable (cT2) prostate cancers in patients undergoing radical retropubic prostatectomy

By Ghavamian R.   Blute M.L.   Bergstralh E.J.   Slezak J.   Zincke H.  

Urology, Vol. 54, Iss. 1, 1999-07 ,pp. : 105-110

Elsevier

Access to resources Recommend Favorite

Management of patients with rising prostate-specific antigen after radical prostatectomy

By Laufer M.   Pound C.R.   Carducci M.A.   Eisenberger M.A.  

Urology, Vol. 55, Iss. 3, 2000-03 ,pp. : 309-315

Elsevier

Access to resources Recommend Favorite

Detection of prostate-specific antigen RNA before and after radical retropubic prostatectomy and transurethral resection of the prostate using ''Light-Cycler''-based quantitative real-time polymerase chain reaction

By Straub B.   Muller M.   Krause H.   Schrader M.   Goessl C.   Heicappell R.   Miller K.  

Urology, Vol. 58, Iss. 5, 2001-11 ,pp. : 815-820

Elsevier

Access to resources Recommend Favorite